Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

247
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
247
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

83
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
83
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

59
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Necrotizing Pancreatitis and Endovascular Stenting of the Portal and Superior Mesenteric Vein: A Case Report.

Case reports in gastroenterology·2026
Same author

A combined preoperative cardiorespiratory fitness and body composition phenotype is associated with major complications after pancreatoduodenectomy, independent of postoperative pancreatic fistula risk.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Preoperative biliary drainage in perihilar cholangiocarcinoma: retrospective multicentre analysis.

BJS open·2026
Same author

Independent validation of the Mosamatic deep learning automated skeletal muscle and adipose tissue segmentation tool in an external Chinese cancer patient cohort.

BJR artificial intelligence·2026
Same author

Obeticholic acid accelerates portal vein embolization-induced liver hypertrophy in rabbits by improving bile salt homeostasis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Mass spectrometry imaging in spatial biology of pancreatic cancer.

The Analyst·2026

Related Experiment Video

Updated: Nov 1, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.7K

[Sarcopenia and Cachexia-associated Risk in Surgery].

Gregory van der Kroft1, Steven W M Olde Damink2, Ulf Peter Neumann1,2

  • 1Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uniklinik RWTH Aachen, Deutschland.

Zentralblatt Fur Chirurgie
|June 21, 2021
PubMed
Summary
This summary is machine-generated.

Cachexia and sarcopenia, characterized by muscle loss, significantly increase cancer patient mortality and postoperative complications. Early identification through clinical tools is crucial for managing these conditions and improving patient outcomes.

More Related Videos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.1K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

677

Related Experiment Videos

Last Updated: Nov 1, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.7K
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.1K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

677

Area of Science:

  • Oncology
  • Geriatrics
  • Clinical Nutrition

Background:

  • Cachexia is a multifactorial syndrome causing involuntary weight loss and muscle decrease.
  • Sarcopenia, the loss of muscle mass and strength, is a key component of cachexia.
  • Cachexia contributes to at least 20% of cancer patient deaths and varies by cancer type.

Purpose of the Study:

  • To highlight the clinical significance of cachexia and sarcopenia.
  • To emphasize their impact on cancer patient mortality and postoperative morbidity.
  • To advocate for the routine use of identification tools for patients at nutritional risk.

Main Methods:

  • Review of cachexia and sarcopenia definitions and clinical impact.
  • Analysis of cachexia incidence across different cancer types.
  • Discussion of existing tools for identifying patients at nutritional risk.

Main Results:

  • Cachexia is a major cause of death in cancer patients, with incidence rates up to 80% in some types.
  • Both cachexia and sarcopenia significantly increase immediate postoperative complication rates.
  • Involuntary weight loss is a key feature but not always clinically apparent, complicating early detection.

Conclusions:

  • Cachexia, sarcopenia, and myosteatosis are critical factors influencing postoperative outcomes.
  • Routine clinical assessment for nutritional risk, including involuntary weight loss and reduced strength, is essential.
  • Early identification and potential preconditioning treatments can mitigate postoperative morbidity.